GSK-partnered Oligonucleotide

About Empirico

Empirico is a private, clinical-stage biotech leveraging a proprietary, integrated platform that combines human genetics and siRNA technology to discover and develop novel genetic medicines for common diseases with high unmet need. The company has built internal capabilities across the entire drug discovery value chain and has established a strategic partnership with GSK for a clinical-stage respiratory program. With a pipeline of clinical and preclinical programs and a seasoned leadership team, Empirico is positioned to advance a new generation of precision therapeutics.

Therapeutic Areas